These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38295740)

  • 1. A rapid and sensitive analytical methodology for the simultaneous biomonitoring of two direct oral anticoagulant drugs and their major metabolites in thromboembolic disordered patients samples for clinical evaluations.
    Prakasham K; Pan TY; Tan CH; Wu CF; Chandra P; Cheng CM; Chen W; Tsai WC; Ponnusamy VK; Wu MT
    J Chromatogr A; 2024 Feb; 1717():464689. PubMed ID: 38295740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of direct oral anticoagulants in human plasma.
    Zhang YF; Liu XQ; Wang Y; Xu X; Zhong MK; Zhang P; Ma CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122952. PubMed ID: 34598085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
    Lagoutte-Renosi J; Le Poupon J; Girard A; Montange D; Davani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():43-49. PubMed ID: 30292948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and sensitive analytical procedure for biomonitoring of organophosphate pesticide metabolites in human urine samples using a vortex-assisted salt-induced liquid-liquid microextraction technique coupled with ultra-high-performance liquid chromatography/tandem mass spectrometry.
    Pasupuleti RR; Tsai PC; Lin PD; Wu MT; Ponnusamy VK
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8565. PubMed ID: 31469446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
    Wiesen MHJ; Blaich C; Streichert T; Michels G; Müller C
    Clin Chem Lab Med; 2017 Aug; 55(9):1349-1359. PubMed ID: 28328524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization by response surface methodology of a dispersive magnetic solid phase extraction exploiting magnetic graphene nanocomposite coupled with UHPLC-PDA for simultaneous determination of new oral anticoagulants (NAOs) in human plasma.
    Ferrone V; Todaro S; Carlucci M; Fontana A; Ventrella A; Carlucci G; Milanetti E
    J Pharm Biomed Anal; 2020 Feb; 179():112992. PubMed ID: 31816472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
    Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D
    J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
    Gouveia F; Bicker J; Santos J; Rocha M; Alves G; Falcão A; Fortuna A
    J Pharm Biomed Anal; 2020 Mar; 181():113109. PubMed ID: 31981828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry.
    Zhang M; Moore GA; Chin PKL
    Ther Drug Monit; 2020 Jun; 42(3):473-480. PubMed ID: 32053549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous determination of direct oral anticoagulants in human plasma.
    Žideková N; Pršo K; Brisudová K; Babálová L; Bolek T; Sivák Š; Kurča E; Mokrý J; Samoš M; Nosáľ V; Kertys M
    J Sep Sci; 2023 Jul; 46(13):e2300084. PubMed ID: 37016565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
    Baldelli S; Cattaneo D; Pignatelli P; Perrone V; Pastori D; Radice S; Violi F; Clementi E
    Bioanalysis; 2016 Feb; 8(4):275-83. PubMed ID: 26808218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum.
    Boehr S; Haen E
    Ther Drug Monit; 2017 Feb; 39(1):66-76. PubMed ID: 27861316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
    Harenberg J; Du S; Wehling M; Zolfaghari S; Weiss C; Krämer R; Walenga J
    Clin Chem Lab Med; 2016 Feb; 54(2):275-83. PubMed ID: 26167981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.
    Slavik L; Jacova J; Friedecky D; Ulehlova J; Tauber Z; Prochazkova J; Hlusi A; Palova M
    Clin Appl Thromb Hemost; 2019; 25():1076029619872556. PubMed ID: 31523979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
    Noguez JH; Ritchie JC
    Methods Mol Biol; 2016; 1383():21-7. PubMed ID: 26660170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous biomonitoring of volatile organic compounds' metabolites in human urine samples using a novel in-syringe based fast urinary metabolites extraction (FaUMEx) technique coupled with UHPLC-MS/MS analysis.
    Gurrani S; Prakasham K; Huang PC; Wu MT; Wu CF; Lin YC; Tsai B; Krishnan A; Tsai PC; Ponnusamy VK
    Chemosphere; 2023 Jul; 329():138667. PubMed ID: 37059207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of triclosan, triclocarban, triclocarban metabolites and byproducts in urine and serum by ultra-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Luo Q; Zhang H; Zhou Y; Liu Z; Cai Z
    Rapid Commun Mass Spectrom; 2021 Jul; 35(14):e9117. PubMed ID: 33928686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
    Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
    Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S; Dyrkorn R; Spigset O; Hegstad S
    Ther Drug Monit; 2018 Jun; 40(3):369-376. PubMed ID: 29578938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.